Tvardi Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $2,569 |
Gross Profit | -47 | 2,569 | ||
EBITDA | -7,563 | -5,527 | -8,822 | -2,039 |
EBIT | -7,587 | -8,869 | -2,386 | |
Net Income | -7,275 | -5,527 | 4,167 | -4,906 |
Net Change In Cash | 0 | 0 | 0 | 2,569 |
Free Cash Flow | -5,685 | -4,257 | -8,865 | -4,692 |
Cash | 20,734 | 21,418 | 20,648 | 11,439 |
Basic Shares | 9,380 | 9,377 | 8,455 | 9,355 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $7,137 | $20,968 | $41,867 |
Gross Profit | -95 | 6,325 | 14,535 | 34,353 |
EBITDA | -26,653 | -62,600 | -117,650 | -83,804 |
EBIT | -26,748 | -62,792 | -117,909 | -85,474 |
Net Income | -18,214 | -70,867 | -118,513 | -85,474 |
Net Change In Cash | 0 | 7,137 | 20,968 | 41,867 |
Free Cash Flow | -23,499 | -61,963 | -21,040 | -17,916 |
Cash | 20,734 | 37,903 | 22,919 | 21,489 |
Basic Shares | 7,783 | 1,520 | 9,355 | 9,355 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.78 |
2025-09-30 | -$0.59 |
2025-06-30 | $0.51 |
2025-03-31 | -$0.50 |
